Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Intravenously Administered BMS-986168 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 randomized, double-blind, placebo-controlled, single ascending dose study of intravenously administered BMS-986168 in healthy subjects has completed, ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tauopathies

Drugs mentioned

• BMS-986168

Snippet

Sponsor: Biogen | Conditions: Tauopathies | Phase 1 | Status: COMPLETED